Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806507 · ClinicalTrials.gov registry record
Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 45
- Enrollment target
NCT00806507: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00806507 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00806507 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn whether different ways of viewing echocardiogram pictures along with blood tests can help to see heart-related side effects of chemotherapy and trastuzumab earlier than the usual tests.
Interventions
- PROCEDURE Echocardiograms
- PROCEDURE Blood Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00806507
The ClinicalTrials.gov registry entry for NCT00806507 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Echocardiograms is the first listed.
NCT00806507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00806507 about?
NCT00806507 is a clinical study titled "Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients". The goal of this clinical research study is to learn whether different ways of viewing echocardiogram pictures along with blood tests can help to see heart-related side effects of chemotherapy and trastuzumab earlier than the usual tests.
What is the current status of trial NCT00806507?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00806507?
The interventions under investigation include: Echocardiograms (PROCEDURE), Blood Test (PROCEDURE).
Who is sponsoring clinical trial NCT00806507?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.